Navigation Links
Champions Oncology Reports Financial Results for the Year Ended April 30, 2012
Date:7/18/2012

ld," "will," "intend," "expect," "anticipate," "plan," and similar expressions to identify forward-looking statements.  One should not place undue reliance on these forward-looking statements.  The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors.  See Champions Oncology's Form 10-K for the fiscal year ended April 30, 2012 for a discussion of such risks, uncertainties and other factors.  Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Oncology's future results, levels of activity, performance or achievements may not meet these expectations.  The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Oncology's expectations, except as required by law. Champions Oncology, Inc.(Dollars in thousands except per share amounts)Reconciliation of GAAP to Non-GAAP Net LossYear Ended April 30 20122011Net loss – GAAP

($8,661)

($3,802)Less: Stock-based compensation

3,323

3,133Net loss - non-GAAP

($5,338)

($669) Reconciliation of GAAP to Non-GAAP Earnings Per Share (EPS)Year Ended April 30 20122011EPS – GAAP

($0.19)

($0.11)Less: Effect of stock-based compensation on EPS

0.08

0.09EPS - non-GAAP

($0.11)

($0.02) Condensed Consolidated Income Statements (Unaudited)Year Ended April 30 20122011% ChangePOS operating revenue

$2,332

$3,382

-31%TOS operating revenue

4,817

3,500

38%  Total operating revenue$7,149$6,8824%Cost of POS

2,356

1,665

42%Cost of TOS

2,543

1,846

'/>"/>
SOURCE Champions Oncology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities
2. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
3. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
4. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
5. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
6. Peer-reviewed Article Reports ProImmune's Immune Formulation 200® Activates the Immune-Support Gene Nrf2.
7. Prosperous Agriculture Reports Outstanding Sales Result for First Half of 2012
8. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012
9. GeneLink Reports First Quarter 2012 Financial Results
10. Genesis Biopharma Mentioned Favorably in BioMedReports Article
11. Vermillion Reports First Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 30, 2014 Today the National ... of grants for the Brain Research through Advancing ... to develop and revolutionize new methods of understanding ... human brain. This first round of grants totaling ... was allocated to more than 100 investigators in ...
(Date:10/1/2014)... September 30, 2014 Award winning ... announces four new-hosted collaboration bundles that combine ... high quality conferencing experiences for low, flat rate ... choose from, businesses have optimized solutions to meet ... include audio only minutes (1K, 5K, 10K ...
(Date:10/1/2014)... The U.S. Department of Labor has ... Edwardsville as part of the Trade Adjustment Assistance Community ... co-administered by the Department of Labor and Department of ... Thomas E. Perez and Secretary of Education Arne Duncan ... grants to nearly 270 colleges across the country. ...
(Date:9/30/2014)... , The researchers etched ... layer. Quantum dots are small structures that spontaneously emit light ... pulse is fired at the photonic crystal, its refractive index ... the electromagnetic field around it. This change can speed up ... As soon as the refractive index recovers its usual value, ...
Breaking Biology Technology:NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 2NIH Awards 15 Grants to CHI Members for BRAIN Initiative Research 3SoundConnect Launches New Audio, Web and Video Bundles 2U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 2U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 3U.S. Dept. of Labor Awards SIUE Nearly $10-Million Grant 4Ultrafast remote switching of light emission 2
... 16, 2010 Quest Diagnostics (NYSE: ... testing, information and services, today announced that its ... 2011/2012 compliant and was certified as a Complete ... Certification Commission for eligible Health Information Technology (CCHIT®), ...
... China Cord Blood Corporation (NYSE: CO ) ("CCBC" ... operator in China, today announced that the Company will hold ... Kong office at 48/F, Bank of China Tower, 1 Garden ... 2011 Hong Kong Time (February 18, 2011 8:00 a.m. U.S. ...
... CHARLES, La., Dec. 15, 2010 Dr. Russell L. ... (the leading organization promoting the research and teaching of ... Energy LLC as the Chairman of its Science Advisory ...  "Dr. Chapman has been one of the preeminent scholars ...
Cached Biology Technology:Quest Diagnostics® Care360™ EHR Receives ONC-ATCB 2011/2012 Certification 2Quest Diagnostics® Care360™ EHR Receives ONC-ATCB 2011/2012 Certification 3Quest Diagnostics® Care360™ EHR Receives ONC-ATCB 2011/2012 Certification 4China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on February 18, 2011 2Dr. Russell L. Chapman Joins Aquatic Energy as the Chairman of its Science Advisory Board 2Dr. Russell L. Chapman Joins Aquatic Energy as the Chairman of its Science Advisory Board 3
(Date:9/30/2014)... comes to using marijuana, new research, involving mice and ... Journal of Leukocyte Biology , suggests that ... you should. That,s because a team of Italian scientists ... serious long-term damage to the immune system. This damage ... such as multiple sclerosis, inflammatory bowel disease and rheumatoid ...
(Date:9/30/2014)... , Sept. 30, 2014  Spectra ... solutions for the biotech and power generation ... new RECONN Bioprocess Manager, an easy-to-use and ... geared towards bioprocess development laboratories. ... disparate bioreactor and analyzer systems. Accessing and ...
(Date:9/29/2014)... study confirms that the exposure to tar tended to ... regular cigarettes. Similarly, exposure to nicotine tended to ... type of cigarette in several countries around the world. ... toxic chemicals in the smoke of these cigarettes are ... levels of chemicals in the smoke are not necessarily ...
Breaking Biology News(10 mins):Adolescent exposure to thc may cause immune systems to go up in smoke 2Spectra Automation Introduces RECONN Bioprocess Manager 2Slim cigarette smokers not exposed to more harmful chemicals 2
... During the 1970s and 1980s, researchers and policymakers ... of sulfur dioxide and nitrogen oxides from the stacks ... In Europe, there was much concern about the effects ... in some cases strikingly acidic. The Swedish government instituted ...
... Norwich Research Park, working with colleagues in China, have ... genomics to breeding the improved varieties of crop needed ... the complicated genome of oilseed rape they have been ... needed for predictive breeding. , Traditional breeding involves ...
... Seventy per cent of eight-month-old babies have a salt ... due to being fed salty and processed foods like yeast ... are also given cows, milk, which has higher levels of ... despite recommendations that it should not be used in this ...
Cached Biology News:Organic carbon suggests Swedish lakes were less acidified 2Dissecting the genomes of crop plants to improve breeding potential 270 percent of 8-month-olds consume too much salt 2
4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to KLH (Keyhole Limpet Hemocyanin) lysine through amide bonds....
Estrogen Receptor (ER) Competitor Assay Kits Green for Estrogen Receptors-alpha and -beta (ER-Alpha and ER-Beta) are ideal for screening novel estrogen receptor binding compounds and endocrine disrup...
Human Aminopeptidase P2/XPNPEP2 Affinity Purified PAb ENTREZ GeneID: 7512...
in vitro Translation, Accessory Products...
Biology Products: